Hua‐Ju Li
Papers
1
Total Citations
86
H-Index
1
About
Hua-Ju Li is a pioneering researcher in regenerative medicine, with a primary focus on cell-based therapies for neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD). Their landmark 1993 study, "Cell Transplantation as an Experimental Treatment for Duchenne Muscular Dystrophy," which has garnered 86 citations, represents a foundational contribution to the field. In this work, Li assessed the feasibility, safety, and efficacy of myoblast transfer therapy (MTT) through an experimental lower body treatment involving 32 DMD boys aged 6–14. By administering 48 injections of five billion normal myoblasts, Li demonstrated both the potential and the challenges of cell transplantation for muscle regeneration. This study not only advanced clinical understanding of DMD treatment but also established critical protocols for future cell therapy trials. Li’s research has had a lasting impact, influencing subsequent investigations into stem cell and gene therapies for muscular dystrophies. Their work remains a key reference for researchers exploring regenerative approaches to degenerative muscle diseases, highlighting both the promise and the hurdles of translating cell transplantation from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1